Where does Heuron Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Heuron Co., Ltd. ranks #24,465 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Heuron Co., Ltd. hold?

Heuron Co., Ltd. holds 11 US utility patents granted between 2021 and 2025, spanning 7 technology areas.

What is Heuron Co., Ltd.'s Innovation Score?

Heuron Co., Ltd. has an Innovation Score of 32.4 out of 100 (41st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Heuron Co., Ltd. focus on?

Heuron Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Heuron Co., Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Heuron Co., Ltd..

What does claim depth mean for Heuron Co., Ltd.'s patents?

Heuron Co., Ltd.'s patents average 13.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Heuron Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Heuron Co., Ltd.

USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Heuron ranks #24,465 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 7 technology areas.

#24,465
of 49,997 US assignees by volume: 41st percentile
by Innovation Score (32.4/100): 13.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24465 · Foreign Corporation #24,465 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #24,465/49,997
PHOTO-FINISH Havah Therapeutics Pty
CPC-NARROW A61B · 7 areas
INNOV-THIN 32.4/100
CLAIMS-RICH 13.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Havah Therapeutics Pty Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Heuron’s 32.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (26%) Velocity 6.7 pts (21%) Breadth 9.4 pts (29%) Claim depth 7.8 pts (24%)

Qualcomm Incorporated · highest

85
Heuron · this assignee

32
3D Lighting… · lowest

7

What this shows Heuron's Innovation Score is 32.4/100 (41st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Heuron?

Each dot is one of Heuron’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Heuron’s own 13.0 claims/patent is at or below the 15.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Heuron vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Heuron's grants concentrate

Heuron Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (5 grants) versus a trough of 1 in 2022. By volume, Heuron sits between Havah Therapeutics Pty Ltd. and Higgins Research & Development, LLC.

Heuron's three-year grant acceleration

Heuron Co., Ltd. shows 5 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Havah Therapeutic…

11
Heatscape com

11
Helmerich & Payne

11
Hesse

11
Hewett-packard De…

11
Hewy Wine Chillers

11
Hi Rel Connectors

11
Higgins Research…

11
Heuron ◀

11

What this shows Heuron holds 11 patents at rank #24,482, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Heuron

By rank, the assignees closest to #24,482 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Heuron's primary technology class.

Heuron's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 41st percentile higher than 41% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Heuron Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	5	45.5%
2022	1	9.1%
2023	2	18.2%
2024	2	18.2%
2025partial year	1	9.1%

Which technologies does Heuron Co., Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

G06T - Image Data Processing OR Generation, IN General 11

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 4

G06N - Computing Arrangements Based ON Specific Computational Models 3

G06F - Electric Digital Data Processing 2

G06V - Image OR Video Recognition OR Understanding 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Heuron Co., Ltd.'s patent record in context - here's where to go next.

Heuron Co., Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #24,465 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Heuron Co., Ltd. against Havah Therapeutics Pty Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.